OptumRx And Catamaran Corp. To Combine - Quick Facts

(RTTNews) - OptumRx, UnitedHealth Group's (UNH) free-standing pharmacy care services business, and Catamaran Corp. (CTRX, CCT.TO) announced merger, which calls for the acquisition of Catamaran's outstanding common stock for $61.50 per share in cash.

The acquisition is expected to be accretive to UnitedHealth Group's net earnings in the area of $0.30 per share in 2016. UnitedHealth Group affirmed its $6.00 to $6.25 per share earnings outlook.

Catamaran offers retail pharmacy network management, mail service pharmacy, pharmacy claims management and patient-centric specialty pharmacy services to a broad client portfolio, including health plans and employers, as well as health care information technology solutions to the industry.

Upon closing, Mark Thierer, Catamaran's chairman and CEO, will serve as CEO of OptumRx and Timothy Wicks, the current CEO of OptumRx, will become president. Jeff Park, who currently serves Catamaran as executive vice president, Operations, will become the chief operating officer for OptumRx. Jeffrey Grosklags, currently the CFO of OptumRx, will continue in the role.